Summary Chinese hamster ovary (CHO) cells were exposed in vitro to combinations of bleomycin and misonidazole under hypoxic conditions. Only one drug was present at any given time and cells were washed before being exposed to the second drug. Both Misonidazole (MISO) has been extensively studied as a radiosensitizer of hypoxic mammalian cells (Adams, 1977) and it is currently being evaluated as an adjunct to radiotherapy in a number of clinical trials (Phillips et al., 1982) . In the course of the investigations of its effects in mammalian cells, it was discovered that MISO is selectively toxic to hypoxic mammalian cells (Hall &. Roizin-Towle, 1975; Moore et al., 1976) . Furthermore, even under conditions where MISO does not itself kill cells, the drug inflicts damage in hypoxic cells which can potentiate the radiosensitivity of those cells (Hall & Biaglow, 1977; Wong et al., 1978) . It has been reported that MISO can also potentiate the effect of chemotherapeutic agents (Roizin-Towle & Hall, 1978; Stratford et al., 1980) . For example, RoizinTowle and Hall showed that inactivation of hypoxic cells by bleomycin can be potentiated by simultaneous treatment with MISO (Roizin-Towle & Hall, 1978.
Summary Chinese hamster ovary (CHO) cells were exposed in vitro to combinations of bleomycin and misonidazole under hypoxic conditions. Only one drug was present at any given time and cells were washed before being exposed to the second drug. Both drugs induced potentially lethal damage (PLD). This damage was repaired under hypoxic conditions very rapidly, and bleomycin-induced PLD was repaired more rapidly than misonidazole-induced PLD. If, after the combined treatment, cells are kept in hypoxia, much of the damage can be repaired.
Misonidazole (MISO) has been extensively studied as a radiosensitizer of hypoxic mammalian cells (Adams, 1977) and it is currently being evaluated as an adjunct to radiotherapy in a number of clinical trials (Phillips et al., 1982) . In the course of the investigations of its effects in mammalian cells, it was discovered that MISO is selectively toxic to hypoxic mammalian cells (Hall &. Roizin-Towle, 1975; Moore et al., 1976) . Furthermore, even under conditions where MISO does not itself kill cells, the drug inflicts damage in hypoxic cells which can potentiate the radiosensitivity of those cells (Hall & Biaglow, 1977; Wong et al., 1978) . It has been reported that MISO can also potentiate the effect of chemotherapeutic agents (Roizin-Towle & Hall, 1978; Stratford et al., 1980) . For example, RoizinTowle and Hall showed that inactivation of hypoxic cells by bleomycin can be potentiated by simultaneous treatment with MISO (Roizin-Towle & Hall, 1978 .
It has been suggested that MISO induces a form of potentially lethal damage (PLD) similar to that demonstrated for ionizing radiation (Korbelik et al., 1981) . Furthermore, it has been proposed that the radiation-toxicity interaction occurs between radiation-indiced PLD and MISO-induced PLD, with both treatments affecting the same target. Bleomycin, too, is a drug which is known to induce PLD-like damage in mammalian cells (Hahn et al., 1982) . Furthermore, it was proposed that this PLD involves DNA as a target molecule (Nakatsugawa et al., 1984) . Bleomycin and MISO are both known to damage DNA Palcic & Skarsgard, 1978 Ltd., 1985 experiment. The drugs were diluted to the desired concentration and the solutions were made hypoxic (as described above) before the addition of cells. At no time during these experiments were both drugs used at the same time. Cells were always treated first with one drug, and then after it was washed away, the cells were exposed to the second drug. During the washing procedure (centrifugation, resuspension in growth medium) the cells were under aerobic conditions, but were kept at 4°C. In some experiments, actinomycin D (Sigma) was substituted for bleomycin.
Bleomycin treatment was expressed in pgmlP' as is customary through the literature, and MISO in molar concentration. Molecular weight of MISO is 201.2 and thus 2mM and 5mM MISO corresponds to 402.4pgml-1 and 1006.0jugml-', respectively.
Hypertonic treatment
In some experiments, the existence of potentially lethal damage was investigated by treatment of cells with hypertonic solution. In this case, the cells were washed free of the drug under investigation and then they were resuspended in hypertonic solution, a 0.5 M NaCl, phosphate buffered saline, pH = 7.2, for 20 min at 370C. Immediately after hypertonic treatment the cells were resuspended in growth medium and plated. Irradiation Cells were irradiated under aerobic conditions always prior to MISO toxicity studies. The cells were suspended in growth medium and irradiated at 4°C to the desired dose of X-rays (270 kVp, HVL 1.7mm Cu, 1.4 Gy min-1). Immediately after irradiation, the cells were made hypoxic and MISO treatment started. Thus, no repair time was allowed between irradiation and MISO exposure.
Results
It has been shown that ionizing radiation reduces the zero-slope shoulder of the cell response to MISO toxicity in hypoxia (Korbelik et al., 1981 ). An example of this phenomenon is shown in Figure 1 Radiation-MISO and Bleomycin-MISO treatment (a) CHO cells were irradiated with X-rays to 7.5 Gy (A) and 11 Gy ('), and then exposed to MISO for the indicated times under hypoxia. Control cells were not exposed to either bleomycin or radiation (0). (b) CHO cells were exposed to bleomycin, 100 /g ml-1 for 1 h at 37°C. After bleomycin was washed away, the cells were made hypoxic and exposed to 2mM MISO at 37°C for the indicated times (O) or they were kept in hypoxia without MISO (*).
Immediately after a sample of cell suspension was withdrawn, the cells were washed and plated. Figure 2 . In this case, the cells were always exposed to MISO as follows: 5mM MISO, 2 h exposure in hypoxia, 37°C. Bleomycin treatment was always for 1 h at 37°C in hypoxia at the indicated bleomycin concentrations. If MISO treatment precedes that of bleomycin, the cell kill was nearly one order of magnitude larger than if the sequence was reversed.
Bleomycin is approximately equally cytotoxic to oxic and hypoxic cells. In these studies we limited our experiments to hypoxic conditions. The possible existence of potentially lethal damage (PLD), inflicted by either bleomycin alone or a bleomycin-MISO combination, was investigated by briefly exposing the cells to hypertonic solution. This procedure has been commonly used to demonstrate the existence of PLD in irradiated cells (Utsumi & Elkind, 1979) . It has also been used to demonstrate the existence of PLD in cells exposed to MISO in hypoxia (Korbelik et al., 1982) . Figure 3 shows the results of an experiment where cells were first exposed to bleomycin alone (50 jg ml -1, hypoxia, 1 h 370C indicated concentrations), or to MISO (5mM, hypoxia, 2 h 370C) followed by bleomycin. Immediately after drug exposure, the cells were washed and plated, or they were first treated with a hypertonic solution Bleomycin (,uLg ml-n) Figure 4 . Cells were always incubated with 2 mM MISO at 37°C in hypoxia for the indicated times. A sample of cell suspension was withdrawn at the prescribed time, the cells were washed free of MISO and the sample was divided into 3 aliquots. The cells were then exposed to 0, 100 or 300Qugml-1 of bleomycin, for I h at 37°C in 0 2 4 6
Time (h) Figure 4 MISO-bleomycin treatment. Cells were exposed to 2mM MISO at 37°C in hypoxia for the indicated times. They were then washed and further exposed to either Opgml-1 (0), l00pgml-1 (A), or 300 ig ml-1 (Ol) bleomycin for h at 37°C in hypoxia. Immediately after treatment, they were washed and plated. For 2mM MISO, after 5 h at 37°C in hypoxia, followed by 1h treatment with 100pugml-1 bleomycin at 37°C in hypoxia, cells were plated immediately after washing (A) or, they were further incubated in hypoxia at 37°C for the indicated times, and then plated (A).
hypoxia. Immediately thereafter, bleomycin was washed away and the cells were plated.
In the case of the 100 gml-1 bleomycin exposure, some samples were kept in hypoxia after the last cell wash before they were plated, in order to examine repair of PLD damage. Indeed, keeping cells in hypoxia before plating them resulted in almost a 100-fold increase in cell survival.
Discussion
The bleomycin-MISO interaction has many similarities to the radiation-MISO interaction. The latter is believed to involve different types of PLD which each modality inflicts on the same target. We believe that this radiation-MISO interaction is simply the result of two types of injuries interfering with each other's respective repair in the same target (Korbelik et al., 1981, and submitted) . We would like to put forward a hypothesis that the same mechanism could explain bleomycin-MISO interaction. Bleomycin induces PLD as can be seen from the hypertonic treatment effects, Figure 3 . MISO, on its own, has also been shown to induce PLD (Korbelik et al., 1982, and submitted) . The coffbined treatment of cells with both drugs (in sequence) enhances the total PLD (Figure 3 ).
It was shown that keeping cells in hypoxia after irradiation resulted in increased cell survival (Korbelik et al., and submitted) . This was explained as repair of PLD. Cells in hypoxia are arrested in their progression through the cell cycle (Koch et al., 1973) , thus giving them time to repair PLD before it is fixed by cell progression. We showed that incubation of cells in hypoxia results in rapid repair of radiation induced PLD, presumably, and there is consequently much less interaction with MISO cytotoxicity (Korbelik et al., and submitted) . It is likely that the initial increase in cell survival after bleomycin exposure is also an expression of PLD repair (Figure 1 ). This is true for cells kept in hypoxia with or without MISO present. The fact that the two curves are indistinguishable up to nearly 3 h, demonstrates that the presence of MISO (2mM) does not interfere with repair of bleomycininduced PLD repair. This is consistent with our observation that repair of radiation-induced PLD under hypoxic conditions is not affected by the presence of MISO (Brown et al., 1981; Korbelik et al., and submitted) . From the data in Figure 1 , it can be estimated that the half time for repair of the bleomycin-induced damage is -1 h or less. This is almost double the rate found for MISO-induced PLD (Korbelik et al., 1982) .
It has been shown for bleomycin MISO combined treatments that the sequences by which (Palcic & Skarsgard, 1978; Wong et al., 1978; Olive, 1979; Taylor et al., 1982; Varghese & Whitmore, 1983) . Bleomycin, too, is known to damage DNA and it has been suggested that DNA damage and cell survival are closely correlated Clarkson & Humphrey, 1976; Iqbal et al., 1976; Hurt et al., 1981 Hurt et al., , 1983 Hurt & Moses, 1984) . We thus propose that the common target for cell inactivation with these two drugs is DNA, and that the interaction between the drugs, as measured by cell survival, is in fact the result of interaction of different lesions in the DNA molecule.
In in vivo situations, it is possible that these drugs may be much less effective than these in vitro results might indicate. -In Figure 4 , the repair kinetics of combined MISO-bleomycin PLD damage is demonstrated. After treatment, cells were washed free of drugs and were either plated immediately or kept in hypoxia for some time before plating. Further incubation in hypoxia increased the survival nearly 100-fold. If a MISObleomycin combination were used in tumour treatments and aimed at chronically hypoxic cells (or even acutely hypoxic cells), then once the drugs were removed by metabolism, repair in hypoxia would greatly diminish their effectiveness. In vivo, one would expect hypoxic cells to remain hypoxic for some time after treatment, before being recruited back into the growth compartment, thus they would have time to repair much of the inflicted damage.
It has been demonstrated that hypoxic cells in vivo can repair radiation-induced PLD (Urano et al., 1976) . This could explain very small additive effects of bleomycin and MISO combination in vivo (Stephens et al., 1981; Randhawa et al., 1982) .
The MISO-bleomycin interaction reduces the zero-slope shoulder of the MISO toxicity response curve, (Figure 4 ). This effect resembles that of the radiation-MISO interaction, where it was demonstrated that cells maintained in normal growth conditions for long periods of time could not repair radiation-induced PLD, while in hypoxia the reverse was true (Korbelik et al., and submitted). We have not yet examined the timecourse of repair for bleomycin induced PLD under these two conditions.
Other chemotherapeutic drugs may resemble bleomycin with respect to interactions arising from PLD. Preliminary results with actinomycin-D show close parallels to the results reported here for bleomycin.
